195 related articles for article (PubMed ID: 30056299)
1. Nivolumab to control molecular response in chronic myeloid leukemia.
Rousselot P; Renard P; de Buyer A; Finet A; Spentchian M; Saiag P
Leuk Res; 2018 Sep; 72():5-6. PubMed ID: 30056299
[No Abstract] [Full Text] [Related]
2. [Combination of two forms of chronic leukemia and solid tumor in one patient].
Tsyba NN; Obukhova TN; Kaplanskaia IB; Kovaleva LG; Tikhonova LIu; Gretsov EM; Misiurin AV
Ter Arkh; 2007; 79(10):73-7. PubMed ID: 18154150
[No Abstract] [Full Text] [Related]
3. Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment?
D'Arena G; Gemei M; Luciano L; D'Auria F; Deaglio S; Statuto T; Bianchino G; Grieco V; Mansueto G; Guariglia R; Pietrantuono G; Martorelli MC; Villani O; Del Vecchio L; Musto P
J Clin Oncol; 2012 Nov; 30(32):e327-30. PubMed ID: 23008321
[No Abstract] [Full Text] [Related]
4. Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.
Orciuolo E; Fazzi R; Galimberti S; Testi C; Azzara' A; Carulli G; Petrini M
Leuk Res; 2006 Mar; 30(3):349-53. PubMed ID: 16182365
[TBL] [Abstract][Full Text] [Related]
5. Favorable early response of secondary chronic myeloid leukemia to imatinib.
Waldman D; Weintraub M; Freeman A; Neumann Y; Rechavi G; Toren A
Am J Hematol; 2004 Apr; 75(4):217-9. PubMed ID: 15054813
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy.
Rosário Cavalheiro Rde C; Vicari P; Maria Morselli F; Ommati LV; Frazão Rosa Fde O; Rodrigues Oliveira JS
Am J Hematol; 2006 Jan; 81(1):76-7. PubMed ID: 16369975
[No Abstract] [Full Text] [Related]
7. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients.
Moumen A; Dehbi H; Kottwitz D; El Amrani M; Bouchoutrouch N; El Hadi H; Quessar A; Benchekroun S; Nadifi S; Sefrioui H
Genet Mol Res; 2015 Feb; 14(1):1044-55. PubMed ID: 25730044
[TBL] [Abstract][Full Text] [Related]
8. Testicular cancer developed in a chronic myeloid leukemia patient with a continued complete cytogenetic and molecular response to imatinib. A case report and review of the literature.
Kata D; Mrówka-Kata K; Seweryn M; Pajak J; Najda J; Kyrcz-Krzemień S
Leuk Res; 2010 Sep; 34(9):e229-31. PubMed ID: 20359744
[No Abstract] [Full Text] [Related]
9. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H; Kuwayama M; Kotake T; Karasuno T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
[TBL] [Abstract][Full Text] [Related]
10. Radotinib-induced eruptive melanocytic nevi in patient with chronic myeloid leukemia: a case report and literature review.
Park E; Jue MS
Ann Hematol; 2019 Feb; 98(2):533-535. PubMed ID: 30032412
[No Abstract] [Full Text] [Related]
11. Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
Breccia M; Martelli M; Cannella L; Russo E; Finolezzi E; Stefanizzi C; Levi A; Frustaci A; Alimena G
Leuk Res; 2008 Feb; 32(2):353-5. PubMed ID: 17825907
[TBL] [Abstract][Full Text] [Related]
12. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
13. How complete is "complete" molecular response in imatinib-treated chronic myeloid leukemia?
Ross DM; Hughes TP
Leuk Lymphoma; 2008 Jul; 49(7):1230-1. PubMed ID: 18604711
[No Abstract] [Full Text] [Related]
14. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission.
Paschka P; Müller MC; Merx K; Kreil S; Schoch C; Lahaye T; Weisser A; Petzold A; König H; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
Leukemia; 2003 Sep; 17(9):1687-94. PubMed ID: 12970765
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
16. [Appearance of a chronic myeloid leukemia in Waldenström's macroglobulinemia].
Majado MJ; González García C; Marín-Blazquez MD; Morales Lázaro A; Moreno Moreno M
Sangre (Barc); 1992 Dec; 37(6):465-6. PubMed ID: 1293799
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous anaplastic large-cell lymphoma occurring in a case of chronic myeloid leukemia in remission.
Charafeddine KM; Farchoukh LO; Khalifeh I
J Cutan Pathol; 2012 Sep; 39(9):884-6. PubMed ID: 22775801
[No Abstract] [Full Text] [Related]
18. Endogenous erythroid colony formation in chronic myeloid leukemia: a recurrent finding associated with persistent minimal residual disease under imatinib.
Einwallner E; Jaeger E; Mitterbauer-Hohendanner G; Bilban M; Simonitsch-Klupp I; Steiner I; Pernicka E; Hoermann G; Herndlhofer S; Sillaber C; Valent P; Schwarzinger I
Stem Cells Dev; 2013 Dec; 22(23):3043-51. PubMed ID: 23883175
[TBL] [Abstract][Full Text] [Related]
19. Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia.
Kubasch AS; Wehner R; Bazzurri S; Tunger A; Stasik S; Garzarolli M; Meinel J; Baretton G; Meier F; Thiede C; Schmitz M; Platzbecker U
Blood Adv; 2018 Jun; 2(11):1187-1190. PubMed ID: 29844203
[TBL] [Abstract][Full Text] [Related]
20. Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia.
Crescenzi B; Sacchi S; Marasca R; Temperani P; La Starza R; Matteucci C; Bonacorsi G; Romoli S; Martelli MF; Mecucci C; Emilia G
Leukemia; 2002 May; 16(5):955-6. PubMed ID: 11986962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
